Casaasdas

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso
Last updated 28 setembro 2024
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Construct validity and responsiveness of the simplified version of
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Translating Improvements with Ixekizumab in Clinical Trial
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
A-D) Disease activity and quality of life change before and after
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Biomolecules, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Microvascular dysfunction in ankylosing spondylitis is associated
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Low BASDAI score alone is not a good predictor of anti-tumor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers Leveraging the tolerogenic potential of TNF-α and
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers The Clinical and MRI Effect of TNF-α Inhibitors in
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Full article: Worse scores but similar patterns of disease
Recomendado para você
você pode gostar

© 2014-2024 immanuelipc.com. All rights reserved.